- Interactive Questions
- Online Chapter
- Further Reading
- Extracts from ELS
- Your feedback
- Become a reviewer
- More student books
- Student apps
- Join an e-mail list
Arhel N. and Kirchhoff F. (2010) Host proteins involved in HIV infection: new therapeutic targets. Biochimica et Biophysica Acta 1802, 313–321.
Badolato R. (2013) Defects of leukocyte migration in primary immunodeficiencies. European Journal of Immunology 43, 1436–1440.
Barouch D.H. and Deeks S.G. (2014) Immunologic strategies for HIV‐1 remission and eradication. Science 345, 169–174.
Broder S. (2010) The development of antiretroviral therapy and its impact on the HIV‐1/AIDS pandemic. Antiviral Research 85, 1–18.
Burton D.R., Poignard P., Stanfield R.L., and Wilson, I.A. (2012). Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337, 183–186.
de Jesus A.A., Canna S.W., Liu Y. and Goldbach‐Mansky R. (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annual Review of Immunology 33, 823–874.
Durandy A., Kracker S., and Fischer A. (2013) Primary antibody deficiencies. Nature Reviews Immunology 13, 519–533.
Fauci A.S. and Marston H.D. (2014) Ending AIDS – is an HIV vaccine necessary? New England Journal of Medicine 370, 495–498.
Fischer A., Hacein‐Bey‐Abina S., and Cavazzana‐Calvo M. (2013) Gene therapy of primary T cell immunodeficiencies. Gene 525, 170–173.
Fodil N., Langlais D., and Gros P.(2016) Primary Immunodeficiencies and Inflammatory Disease: A Growing Genetic Intersection. Trends in Immunology 37, 126–140.
Greene W.C. and Peterlin B.M. (2002) Charting HIV’s remarkable voyage through the cell: basic science as a passport to future therapy. Nature Medicine 8, 673–680.
Klasse P.J., Shattock R., and Moore J.P. (2008) Antiretroviral drug‐based microbicides to prevent HIV‐1 sexual transmission. Annual Review of Medicine 59, 455–471.
Kohn D.B. (2010) Update on gene therapy for immunodeficiencies. Clinical Immunology 135, 247–254.
Malim M.H. and Bieniasz P.D. (2012) HIV restriction factors and mechanisms of evasion. Cold Spring Harbor Perspectives in Medicine 2, a006940.
Malim M.H. and Emerman M. (2008) HIV‐1 accessory proteins – ensuring viral survival in a hostile environment. Cell Host & Microbe 3, 388–398.
McMichael A.J., Borrow P., Tomaras G.D., Goonetilleke N., and Haynes B.F. (2010) The immune response during acute HIV‐1 infection: clues for vaccine development. Nature Reviews Immunology 10, 11–23.
Milner J.D. and Holland S.M. (2013) The cup runneth over: lessons from the ever‐expanding pool of primary immunodeficiency diseases. Nature Reviews Immunology 13, 635–648.
Mukherjee S. and Thrasher A.J. (2013) Gene therapy for PIDs: progress, pitfalls and prospects. Gene 525, 174–181.
Ochs H.D., Smith C.I.E., and Puck J.M. (eds.) (2013) Primary Immunodeficiency Diseases – A Molecular and Genetic Approach, 3rd edn. Oxford University Press, Oxford.
Orange J.S. (2013) Natural killer cell deficiency. Journal of Allergy and Clinical Immunology 132, 515–525.
Picard C., Al‐Herz W., Bousfiha A. et al. (2015) Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. Journal of Clinical Immunology 35, 696–726.
Richman D.D., Margolis D.M., Delaney M., Greene W.C., Hazuda D., and Pomerantz R.J. (2009) The challenge of finding a cure for HIV infection. Science 323, 1304–1307.
Sharp P.M. and Hahn B.H. (2008) AIDS: prehistory of HIV‐1. Nature 455, 605–606.
Siliciano R.F. and Greene W.C. (2011) HIV latency. Cold Spring Harbor Perspectives in Medicine 1, a007096.
Skattum L., van Deuren M., van der Poll T., and Truedsson L. (2011) Complement deficiency states and associated infections. Molecular Immunology 48, 1643–1655.
Tilton J.C. and Doms R.W. (2010) Entry inhibitors in the treatment of HIV‐1 infection. Antiviral Research 85, 91–100.
Walker B.D. and Yu X.G. (2013) Unravelling the mechanisms of durable control of HIV‐1. Nature Reviews in Immunology 13, 487–498.
Copyright © 2017 Peter J. Delves, Seamus J. Martin, Dennis R. Burton, Ivan M. Roitt